NuVasive Precice System Lawsuits

NuVasive issued a recall for its limb lengthening Precice system implant over biocompatibility concerns in February 2021. People are filing lawsuits for injuries related to biocompatibility problems such as bone abnormalities, tissue degradation and bone degradation.

This is an active lawsuit
See if you can file

See If You Qualify for a NuVasive Precice Lawsuit

If you received an adjustable NuVasive Precice implant and suffered serious injuries, you may be eligible for compensation. Get a free case review.

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.
Last Modified: December 14, 2021
Fact Checked
Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch?

Drugwatch.com has been empowering patients for more than a decade

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

About Drugwatch.com

  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us

Testimonials

"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Why Are People Suing NuVasive?

People are suing NuVasive because the company’s Precice devices could lead to biocompatibility issues. Biocompatibility is a measure of how well an implant does in the body without causing rejection or other problems. Bio-incompatibility may cause tissue reactions, inflammation, immune responses, cancer and other negative reactions.

On July 8, 2021, the Food and Drug Administration issued a letter to health care providers warning them of potential biocompatibility concerns with Precice devices. The FDA received reports of pain, changes in soft tissue and changes in the bone surrounding the stainless steel Precice Stryde device.

So far, the agency hasn’t received reports of problems with Precice implants made from titanium. In December 2021, the FDA advised the public that the benefits for patients using titanium Precise devices outweigh the risks compared to alternative treatments.

Which Precice Devices Have Been Recalled?

NuVasive pulled all Precice stainless steel devices from the U.S. market in February 2021 because of side effects such as pain and bone changes in patients using the Precice Stryde device. The problems seem to occur where the telescoping (moving) segments of the nail come together, according to NuVasive. However, the company hasn’t confirmed the exact cause for the adverse events.

The company also initiated a recall for the titanium Precice devices for biocompatibility testing in February 2021. They did not withdraw them from the market at that time, but they did place a shipping hold on titanium Precice devices in April 2021. That shipping hold was officially lifted in November 2021.

In addition, the CE certification for the company’s MAGEC and Precice systems in Europe was suspended and all sales of the device have been put on hold.

“At this time, the FDA is uncertain if the root cause of these adverse events is due to the stainless-steel material or related to design features and materials common to all Precice devices.” — FDA”

Stainless Steel

Patients with stainless steel Precice devices have reported pain and changes in surrounding bone and soft tissue. According to the FDA, these side effects may be related to corrosion, wear, and previously unanticipated exposure of components.

In the FDA’s letter to health care providers, the agency noted that it is working to evaluate new testing to address biocompatibility issues. NuVasive and the FDA are working together to collect more data that can provide insights into the causes of the complications and to make sure patients who currently have a Precice device are properly monitored.

Recalled stainless steel (Biodur 108)-based Precice devices include:
  • Precice Bone Transport
  • Precice Plate
  • Precice Stryde

At this time, the FDA is not recommending the early removal of devices in people who are not experiencing any reactions to their current stainless steel Precice devices. The agency does urge patients and their doctors to check for changes “during routine radiographic monitoring” and pay close attention to any unexpected symptoms, such as pain.

Titanium-based

So far, the FDA hasn’t received reports of biocompatibility issues stemming from titanium-based Precice devices. NuVasive is currently investigating these devices for potential connections to the adverse events seen with stainless steel devices.

Recalled titanium-based Precice devices include:
  • Precice Freedom
  • Precice Intramedullary Limb Lengthening (IMLL) Device
  • Precice Short
  • Precice Unyte

While titanium is known for its favorable biocompatibility, implants made with this metal also have some disadvantages, according to a 2020 study published in Materials.

“These include low biologic activity, which reduces the growth of fibrous tissue and allows loosening of the prosthesis, the possibility of metallosis and related inflammation or other allergic reactions, as well as abrasion of the material during operation,” authors write.

On Dec. 1, 2021, the FDA released an update on titanium-based devices that had been removed from the market as a precaution. On Nov. 30, 2021, the ship hold for these devices was removed.

“The FDA believes it is in the best interest of patients to make titanium-based Precice devices available in the United States. At this time, the overall benefits of the devices outweigh the known risks for on-label use with the updated labeling, compared to alternative treatments,” the agency said.

Did you experience tissue reactions, bone complications or other problems from a NuVasive Precice device?

Injuries Named in Lawsuits against NuVasive

Injuries related to biocompatibility are the main focus of Precice lawsuits, these include tissue reactions, bone problems and other complications stemming from the body reacting poorly to the implant.

For example, one 2021 study published in Acta Othropaedica noted that patients with Stryde implants had pain and abnormal bone growth at the nail junction. Researchers found 20 out of 23 retrieved nails had corrosion and discoloration. They also found biological material inside the nail.

Study authors concluded the design of the screw holes and locking screws may have contributed to the patients’ health problems.

NuVasive is investigating potential health problems, such as cancer, chronic toxicity, developmental toxicity and reproductive toxicity, linked to biocompatibility problems with its Precice devices.

People with the following injuries may qualify to file a Precice lawsuit:
  • Bone abnormalities
  • Bone degradation
  • Cancer
  • Developmental effects
  • Pain
  • Reproductive system problems
  • Skin irritation or burns
  • Tissue death (necrosis) around the implant
  • Thrombosis
  • Tissue degradation

Who Can File a Lawsuit?

If you received an adjustable Precice implant, suffered injuries from the device and you were 18 or older at the time of implantation, you may qualify to file a lawsuit. Patients must have received the Precice device on or after January 1, 2013.

If you had a device implanted in your leg to help your leg grow and it was adjusted with magnets, you may have had a Precice implant. If you aren’t sure what brand of implant you received, an attorney can help you determine the brand of your device.

There is a time limit to file called a statute of limitations. Make sure you contact an attorney right away, or you may lose your right to file a Precice lawsuit for potential compensation.

Please seek the advice of a medical professional before making health care decisions.